Angiotensin-converting enzyme inhibitors (ACE)
Showing 1 - 25 of 7,591
Chagas Cardiomyopathy Trial in São Paulo (Sacubitril / Valsartan Oral Tablet [Entresto], Enalapril)
Recruiting
- Chagas Cardiomyopathy
- Sacubitril / Valsartan Oral Tablet [Entresto]
- Enalapril
-
São Paulo, BrazilHeart Institute (Incor) University of Sao Paulo
May 6, 2021
Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)
Recruiting
- Kidney Disease
- Bremelanotide
- RAAS inhibition therapy
-
Chula Vista, California
- +5 more
Jan 23, 2023
Coronavirus Disease 2019 Patients Receiving Receiving
Completed
- COVID-19
- Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB)
-
Riyadh, Saudi ArabiaKing Faisal Specialist Hospital & Research Centre
Aug 1, 2020
Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor Trial in Saint Louis (High ACE Activity Fresh Frozen Plasma, Normal
Recruiting
- Angioedema Caused by Angiotensin-Converting-Enzyme Inhibitor
- High ACE Activity Fresh Frozen Plasma
- Normal Saline
-
Saint Louis, MissouriBarnes-Jewish Hospital
Oct 24, 2022
Tranexamic Acid for Angiotensin-converting Enzyme
Completed
- Angioedema
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Angiotensin Converting Enzyme Inhibitors and Angiotensin
Not yet recruiting
- COVID-19 Pneumonia
- Covid_19
- (no location specified)
Jun 5, 2022
Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2
Recruiting
- Diabetes Mellitus
- Cardiovascular Diseases
- Renin-angiotensin-aldosterone system inhibitors
- +2 more
-
Singapore, SingaporeSingapore General Hospital (SGH)
Apr 28, 2021
Angiotensin Converting Enzyme Inhibitors and Incident
Unknown status
- Covid-19, Coronavirus, Angiotensin Converting Enzyme Inhibitors, Influenza, Electronic Health Records, Epidemiology, Comorbidity, Incidence, United Kingdom
- ACE inhibitor
- (no location specified)
Nov 11, 2020
Bradykinin-degradating Enzymes Activities in
Recruiting
- Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
- Assay of Bradykinin-degradating enzymes.
-
Grenoble, FranceChu Grenoble Alpes
Jan 14, 2022
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li,MD
Apr 18, 2023
Hydrochlorothiazide and Risk of Skin Cancer
Completed
- Non-melanoma Skin Cancer
- +2 more
- Hydrochlorothiazide
- Angiotensin-converting enzyme (ACE) inhibitors
-
Montreal, Quebec, CanadaCentre for Clinical Epidemiology, Lady Davis Institute, Jewish G
Mar 8, 2021
Vascular Access Complication Trial in Rawalpindi (Losartan Potassium, multi-vitamins)
Recruiting
- Vascular Access Complication
- Losartan Potassium
- multi-vitamins
-
Rawalpindi, Punjab, PakistanAnas Bin Saif
Nov 22, 2021
Angiotensin Converting Enzyme rs Gene Polymorphism and
Recruiting
- Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases
- DNA extraction AND Real- time polymerase chain reaction analysis to POLYMORPHISM OF in in-stent restenosis (ISR) in CAD
-
Sohag, EgyptSohag university Hospital
Sep 20, 2023
Type 2 Diabetes, Hypertension Trial in Nashville (Placebo, Sitagliptin, Aprepitant)
Completed
- Type 2 Diabetes Mellitus
- Hypertension
- Placebo
- +3 more
-
Nashville, TennesseeVanderbilt University
Feb 8, 2022
Chronic Kidney Diseases Trial (Placebo, Co-Enzyme Q10)
Not yet recruiting
- Chronic Kidney Diseases
- Placebo
- Co-Enzyme Q10
- (no location specified)
Jul 4, 2023
Angiotensin Converting Enzyme in Systemic Lupus Erythematous
Not yet recruiting
- Systemic Lupus Erythematosus
- Angiotensin Converting Enzyme test
-
Sohag, EgyptSohag University Hospital
Aug 24, 2022
Precision Treatment With Angiotensin Converting Enzyme Inhibitor
Recruiting
- Hypertension
- +2 more
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Sep 7, 2022
AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)
Recruiting
- AML
- Acute Myeloid Leukemia
-
Charlottesville, VirginiaUniversity of Virginia
Jul 2, 2022
Diabetic Nephropathy Type 2 Trial (Empagliflozin 25 MG, Enalapril Maleate 20 mg)
Not yet recruiting
- Diabetic Nephropathy Type 2
- Empagliflozin 25 MG
- Enalapril Maleate 20 mg
- (no location specified)
May 9, 2022
Surgery, Angiotensin Hypertension, Perioperative Complication Trial in Netherlands (drug, diagnostic test, behavioral)
Recruiting
- Surgery
- +2 more
- Perioperative withdrawal of angiotensin converting enzyme inhibitors and angiotenin receptor blockers
- +4 more
-
Amsterdam, Netherlands
- +6 more
Jan 6, 2022
Chronic Kidney Diseases Trial (Placebo, Vitamin K 2)
Not yet recruiting
- Chronic Kidney Diseases
- Placebo
- Vitamin K 2
- (no location specified)
Jul 4, 2023
Cardiovascular Disease, Chronic Kidney Disease Trial in Madison (angiotensin converting enzyme inhibitor, lisinopril)
Completed
- Cardiovascular Disease
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitor
- lisinopril
-
Madison, WisconsinUniversity of Wisconsin-Madison Hospitals and Clinics
Oct 8, 2020
Angiotensin Converting Enzyme, Brain, Gut Dysbiosis in Pulmonary
Active, not recruiting
- Pulmonary Arterial Hypertension
-
Jacksonville, Florida
- +1 more
Jan 10, 2022
Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors
Not yet recruiting
- Aortic Valve Stenosis
- Angiotensin Receptor-Neprilysin Inhibitor
- antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
-
Seoul, Korea, Republic ofAsan Medical Center
Jan 4, 2023
COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II
Recruiting
- COVID-19
- Cardiovascular Diseases
- Angiotensin converting enzyme inhibitor
- Angiotensin II Receptor Blockers
-
Maceio, Alagoas, Brazil
- +30 more
Jan 13, 2023